Back to Search
YMA OSORIO, M.D.
M.D.
Obstetrics & Gynecology Physician
NPI: 1255538336Individual
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
17212(PR)
Research & Publications (20)
Pregnancy enhances the innate immune response in experimental cutaneous leishmaniasis through hormone-modulated nitric oxide production.
PMID 18347075·J Leukoc Biol·2008
7-preclinical
A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice.
PMID 17898051·J Virol·2007
7-preclinical
The corneas of naive mice contain both CD4+ and CD8+ T cells.
PMID 17960132·Mol Vis·2007
7-preclinical
Role of anti-glycoproteins D (anti-gD) and K (anti-gK) IgGs in pathology of herpes stromal keratitis in humans.
PMID 17460278·Invest Ophthalmol Vis Sci·2007
7-preclinical
Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis.
PMID 17178178·Vaccine·2007
7-preclinical
Epitope mapping of HSV-1 glycoprotein K (gK) reveals a T cell epitope located within the signal domain of gK.
PMID 17499382·Virus Res·2007
7-preclinical
Pathogenicity and protective immunogenicity of cysteine proteinase-deficient mutants of Leishmania mexicana in non-murine models.
PMID 16216395·Vaccine·2006
7-preclinical
Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana.
PMID 15620471·Vaccine·2005
7-preclinical
CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
PMID 15817260·Exp Neurol·2005
4-observational
Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
PMID 15731224·J Virol·2005
4-observational
Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines.
PMID 14744892·Invest Ophthalmol Vis Sci·2004
4-observational
[Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
PMID 15678803·Biomedica·2004
7-preclinical
The site of cutaneous infection influences the immunological response and clinical outcome of hamsters infected with Leishmania panamensis.
PMID 12911522·Parasite Immunol·2003
7-preclinical
Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
PMID 12719570·J Virol·2003
4-observational
Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.
PMID 12186890·J Virol·2002
7-preclinical
Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp.
PMID 11953362·Infect Immun·2002
7-preclinical
Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice.
PMID 12457985·Virus Res·2002
7-preclinical
The role of T(H)1 and T(H)2 cytokines in HSV-1-induced corneal scarring.
PMID 12778346·Ocul Immunol Inflamm·2002
4-observational
Enhanced clearance of herpes simplex virus type 1 and reduced herpetic eye disease in STAT6 knockout mice is associated with increased IL-2.
PMID 12441072·Virology·2002
7-preclinical
Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
PMID 12429523·Virology·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- CALLE GEN VALERO, SUITE 207
FAJARDO, PR 00738 - Phone
- (787) 365-8362
Quick Facts
- NPI
- 1255538336
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile